263
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Optimization of novel pentablock copolymer based composite formulation for sustained delivery of peptide/protein in the treatment of ocular diseases

, , , , &
Pages 103-113 | Received 02 Nov 2014, Accepted 09 Nov 2015, Published online: 11 Mar 2016

References

  • Bakri SJ, Snyder MR, Reid JM, Pulido JS, Singh RJ. Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology, 2007;114:855–9.
  • Bilati U, Allemann E, Doelker E. Sonication parameters for the preparation of biodegradable nanocapsules of controlled size by the double emulsion method. Pharm Dev Technol, 2003;8:1–9.
  • Bilati U, Allemann E, Doelker E. Poly(d, l-lactide-co-glycolide) protein-loaded nanoparticles prepared by the double emulsion method–processing and formulation issues for enhanced entrapment efficiency. J Microencapsul, 2005;22:205–14.
  • Frank A, Rath SK, Venkatraman SS. Controlled release from bioerodible polymers: Effect of drug type and polymer composition. J Control Release, 2005;102:333–44.
  • Fu K, Pack DW, Klibanov AM, Langer R. Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm Res, 2000;17:100–6.
  • Gou M, Gong C, Zhang J, Wang X, Wang X, Gu Y, Guo G, Chen L, Luo F, Zhao X, et al. Polymeric matrix for drug delivery: Honokiol-loaded PCL–PEG–PCL nanoparticles in PEG–PCL–PEG thermosensitive hydrogel. J Biomed Mater Res A, 2010;93:219–26.
  • Hirani A, Grover A, Lee YW, Pathak Y, Sutariya V. Triamcinolone acetonide nanoparticles incorporated in thermoreversible gels for age-related macular degeneration. Pharm Dev Technol, 2016;21:61–7.
  • Huang MH, Li S, Coudane J, Vert M. Synthesis and characterization of block copolymers of e-caprolactone and d,l-lactide initiated by ethylene glycol or poly(ethylene glycol). Macromol Chem Phys, 2003;204:1994–2001.
  • Huang MH, Li S, Hutmacher DW, Schantz JT, Vacanti CA, Braud C, Vert M. Degradation and cell culture studies on block copolymers prepared by ring opening polymerization of epsilon-caprolactone in the presence of poly(ethylene glycol). J Biomed Mater Res A, 2004;69:417–27.
  • Jager RD, Aiello LP, Patel SC, Cunningham ET, Jr. Risks of intravitreous injection: A comprehensive review. Retina, 2004;24:676–98.
  • Jia W, Gu Y, Gou M, Dai M, Li X, Kan B, Yang J, Song Q, Wei Y, Qian Z. Preparation of biodegradable polycaprolactone/poly (ethylene glycol)/polycaprolactone (PCEC) nanoparticles. Drug Deliv, 2008;15:409–16.
  • Kulkarni AD, Kuppermann BD. Wet age-related macular degeneration. Adv Drug Deliv Rev, 2005;57:1994–2009.
  • Kumar TR, Soppimath K, Nachaegari SK. Novel delivery technologies for protein and peptide therapeutics. Curr Pharm Biotechnol, 2006;7:261–76.
  • Lee SH, Zhang Z, Feng SS. Nanoparticles of poly(lactide)–tocopheryl polyethylene glycol succinate (PLA–TPGS) copolymers for protein drug delivery. Biomaterials, 2007;28:2041–50.
  • Li S, Dobrzynski P, Kasperczyk J, Bero M, Braud C, Vert M. Structure–property relationships of copolymers obtained by ring-opening polymerization of glycolide and epsilon-caprolactone. Part 2. Influence of composition and chain microstructure on the hydrolytic degradation. Biomacromolecules, 2005;6:489–97.
  • Li S, Molina I, Martinez MB, Vert M. Hydrolytic and enzymatic degradations of physically crosslinked hydrogels prepared from PLA/PEO/PLA triblock copolymers. J Mater Sci Mater Med, 2002;13:81–6.
  • Liu CB, Gong CY, Huang MJ, Wang JW, Pan YF, Zhang YD, Li GZ, Gou ML, Wang K, Tu MJ, et al. Thermoreversible gel–sol behavior of biodegradable PCL–PEG–PCL triblock copolymer in aqueous solutions. J Biomed Mater Res Part B Appl Biomater, 2008;84:165–75.
  • Ozturk BT, Kerimoglu H, Bozkurt B, Okudan S. Comparison of intravitreal bevacizumab and ranibizumab treatment for diabetic macular edema. J Ocul Pharmacol Ther, 2011;27:373–7.
  • Perez C, Castellanos IJ, Costantino HR, Al-Azzam W, Griebenow K. Recent trends in stabilizing protein structure upon encapsulation and release from bioerodible polymers. J Pharm Pharmacol, 2002;54:301–13.
  • Peyman GA, Lad EM, Moshfeghi DM. Intravitreal injection of therapeutic agents. Retina, 2009;29:875–912.
  • Pistel KF, Kissel T. Effects of salt addition on the microencapsulation of proteins using W/O/W double emulsion technique. J Microencapsul, 2000;17:467–83.
  • Pourcelle V, Devouge S, Garinot M, Preat V, Marchand-Brynaert J. PCL–PEG-based nanoparticles grafted with GRGDS peptide: Preparation and surface analysis by XPS. Biomacromolecules, 2007;8:3977–83.
  • Putney SD. Encapsulation of proteins for improved delivery. Curr Opin Chem Biol, 1998;2:548–52.
  • Radivojsa M, Grabnar I, Ahlin Grabnar P. Thermoreversible in situ gelling poloxamer-based systems with chitosan nanocomplexes for prolonged subcutaneous delivery of heparin: Design and in vitro evaluation. Eur J Pharm Sci, 2013;50:93–101.
  • Sampat KM, Garg SJ. Complications of intravitreal injections. Curr Opin Ophthalmol, 2010;21:178–83.
  • Sayen A, Hubert I, Berrod JP. Age related macular degeneration. Rev Prat, 2011;61:159–64.
  • Singh S, Webster DC, Singh J. Thermosensitive polymers: Synthesis, characterization, and delivery of proteins. Int J Pharm, 2007;341:68–77.
  • Tang Y, Singh J. Biodegradable and biocompatible thermosensitive polymer based injectable implant for controlled release of protein. Int J Pharm, 2009;365:34–43.
  • Van de Weert M, Hennink WE, Jiskoot W. Protein instability in poly (lactic-co-glycolic acid) microparticles. Pharm Res, 2000;17:1159–67.
  • Zablotna E, Jaskiewicz A, Legowska A, Miecznikowska H, Lesner A, Rolka K. Design of serine proteinase inhibitors by combinatorial chemistry using trypsin inhibitor SFTI-1 as a starting structure. J Pept Sci, 2007;13:749–55.
  • Zhang JX, Zhu KJ, Chen D. Preparation of bovine serum albumin loaded poly (d, l-lactic-co-glycolic acid) microspheres by a modified phase separation technique. J Microencapsul, 2005;22:117–26.
  • Zhang Y, Schwendeman SP. Minimizing acylation of peptides in PLGA microspheres. J Control Release, 2012;162:119–26.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.